diclofenac has been researched along with Bile Duct Obstruction in 7 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cholestasis is one of the major causes of drug-induced liver injury (DILI), which can result in withdrawal of approved drugs from the market." | 1.46 | Mechanism-based risk assessment strategy for drug-induced cholestasis using the transcriptional benchmark dose derived by toxicogenomics. ( Honda, H; Ito, Y; Kawamoto, T; Morita, O, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Alhaddad, O | 1 |
| Elsabaawy, M | 1 |
| Abdelsameea, E | 1 |
| Abdallah, A | 1 |
| Shabaan, A | 1 |
| Ehsan, N | 1 |
| Elrefaey, A | 1 |
| Elsabaawy, D | 1 |
| Salama, M | 1 |
| Kawamoto, T | 1 |
| Ito, Y | 1 |
| Morita, O | 1 |
| Honda, H | 1 |
| Fok, KC | 1 |
| Bell, CJ | 1 |
| Read, RB | 1 |
| Eckstein, RP | 1 |
| Jones, BE | 1 |
| Lacroix, I | 1 |
| Lapeyre-Mestre, M | 1 |
| Bagheri, H | 1 |
| Pathak, A | 1 |
| Montastruc, JL | 1 |
| Zaragoza Marcet, A | 1 |
| Alfonso Moreno, V | 1 |
| Roig Catalá, E | 1 |
| Schneider, HT | 1 |
| Nuernberg, B | 1 |
| Dietzel, K | 1 |
| Brune, K | 1 |
| Hovette, P | 1 |
| Touze, JE | 1 |
| Debonne, JM | 1 |
| Delmarre, B | 1 |
| Rogier, C | 1 |
| Schmoor, P | 1 |
| Aubry, P | 1 |
1 review available for diclofenac and Bile Duct Obstruction
| Article | Year |
|---|---|
[NSAID-induced hepatotoxicity: aceclofenac and diclofenac].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Induced Liver Injury; Cholestasis; Diclof | 1995 |
6 other studies available for diclofenac and Bile Duct Obstruction
| Article | Year |
|---|---|
Presentations, Causes and Outcomes of Drug-Induced Liver Injury in Egypt.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Amoxicillin-Potassium Clavulanate Combination; An | 2020 |
Mechanism-based risk assessment strategy for drug-induced cholestasis using the transcriptional benchmark dose derived by toxicogenomics.
Topics: Administration, Oral; Animals; Chlorpromazine; Cholestasis; Cholesterol; Cyclosporine; Diclofenac; D | 2017 |
Lumiracoxib-induced cholestatic liver injury.
Topics: Aged, 80 and over; Chemical and Drug Induced Liver Injury; Cholestasis; Cyclooxygenase 2 Inhibitors; | 2013 |
Nonsteroidal anti-inflammatory drug-induced liver injury: a case-control study in primary care.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Cholestasis; Diclofenac; Drug Therapy | 2004 |
Biliary elimination of non-steroidal anti-inflammatory drugs in patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Bile; Cholestasis; Common B | 1990 |
[Cholestatic hepatitis and acute kidney insufficiency during treatment with diclofenac].
Topics: Acute Kidney Injury; Aged; Chemical and Drug Induced Liver Injury; Cholestasis; Diclofenac; Female; | 1989 |